参考文献/References:
[1]刘海云.癌症相关MicroRNA检测及成像研究[D].济南:山东师范大学,2014.
[2]HARIS M, YADAV S K, RIZWAN A, et al. Molecular magnetic resonance imaging in cancer[J]. J Transl Med, 2015, 13(1): 1-16.
[3]ROSI N L, MIRLIN C A. Nanostructures in biodiagnostics[J]. Chem Rev, 2005, 105(4): 1547-1562.
[4]MEDINTZ I L, UYEDA H T, GOLDMAN E R, et al. Quantum dot bioconjugates for imaging, labeling and sensing[J]. Nat Mater, 2005, 4(6): 435-446.
[5]CAO Y C, JIN R, MIRKIN C A. Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection[J]. Science, 2002, 297(5586): 1536-1540.
[6]ELIAS D R, CHENG Z, TSOURKAS A. An intein-mediated site-specific click conjugation strategy for improved tumor targeting of nanoparticle systems[J]. Small, 2010, 6(21): 2460-2468.
[7]WSISSLEDER R, PITTET M J. Imaging in the era of molecular oncology[J]. Nature, 2008, 452(7187): 580-589.
[8]DEGEN C L, POGGIO M, MAMIN H J, et al. Nanoscale magnetic resonance imaging[J]. Proc Natl Acad Sci USA, 2009, 106(5): 1313-1317.
[9]QIAO R R, YANG C H, GAO M Y. Superparamagnetic iron oxide nanoparticles: From preparations to in vivo MRI applications[J]. J Mater Chem, 2009, 19(19): 6274-6293.
[10]SUN C, LEE J S H, ZHANG M Q. Magnetic nanoparticles in MR imaging and drug delivery[J]. Adv Drug Deliv Rev, 2008, 60(11): 1252-1265.
[11]JUN Y W, LEE J H, CHEON J. Chemical design of nanoparticle probes for high-performance magnetic resonance imaging[J]. Angew Chem Int Ed, 2008, 47(28):5122-5135.
[12]COROT C, ROBERT P, IDEE J M,et al. Recent advances in iron oxide nanocrystal technology for medical imaging[J]. Adv Drug Deliv Rev, 2006, 58(14): 1471-1504.
[13]WAGNER V, DULLAART A, BOCK A K, et al. The emerging nanomedicine landscape[J]. Nat Biotechnol, 2006, 24(10): 1211-1217.
[14]SKIDMORE F M, DAVIDSON M, DONDA R S. Atomic magnetometer sensor array magnetic resonance imaging systems and methods: US9167979[P]. 2015-10-27.
[15]刘珍宝,石依倩,陈长仁,等.核酸适配体在肿瘤靶向治疗中应用的研究进展[J].科学通报,2014(14):1267-1279.
[16]孙汉文,张彦聪,宋新峰.等.超顺磁性氧化铁纳米粒子在肿瘤靶向诊断治疗中的应用进展[J].中国材料进展,2016,35(3):233-236.
[17]NORDMEYER D, STUMPF P, HOFMANN A, et al. Iron oxide nanoparticles stabilized with dendritic polyglycerols as selective MRI contrast agents[J]. Nanoscale, 2014, 6(16): 9646-9654.
[18]SENETERRE E, TAOUREL P, BOUVIER Y, et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography[J]. Radiology, 1996, 200(3): 785-792.
[19]王瀚.多肽分子在肿瘤研究中的应用[J].绵阳师范学院学报,2014,33(11):53-56.
[20]PASQUALINI R, RUOSLAHTI E. Organ targeting in vivo using phage display peptide libraries[J]. Nature, 1996, 380(6572): 364-366.
[21]ARAP W, PASQUALINI R, RUOSLAHTI E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model[J]. Science, 1998, 279(5349): 377-380.
[22]SUN C, VEISEH O, GUNN J, et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes[J]. Small, 2008, 4(3): 372-379.
[23]LI Z J, WU W K K, NG S S M, et al. A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery[J]. J Control Release, 2010, 148(3): 292-302.
[24]王建浩,李志杰,邱琳,等.基于靶向多肽的量子点探针用于结肠癌肿瘤组织识别[J]. 科学通报,2013,58(7):556-560.
[25]SINGH A, SAHOO S K. Magnetic nanoparticles: a novel platform for cancer theranostics[J]. Drug Discov Today, 2014, 19(4): 474-481.
[26]LEWIN M, CARLESSO N, TUNG C H, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells[J]. Nat Biotechnol, 2000, 18(4): 410-414.
[27]XIE J, CHEN K, LEE H Y, et al. Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)-beta(3)-rich tumor cells[J]. J Am Chem Soc, 2008, 130(24): 7542-7543.
[28]HUANG G, ZHANG C, LI S, et al. A novel strategy for surface modification of superparamagnetic iron oxide nanoparticles for lung cancer imaging[J]. J Mater Chem, 2009, 19: 6367-6372.
[29]SUNDERLAND C J, STEIERT M, TALMADGE J E, et al. Targeted nanoparticles for detecting and treating cancer[J]. Drug Develop Res, 2006, 67(1): 70-93.
[30]MONTET X, FUNOVICS M, MONTET-ABOU K, et al. Multivalent effects of RGD peptides obtained by nanoparticle display[J]. J Med Chem, 2006, 49(20): 6087-6093.
[31]ZHANG C F, JUGOLD M, WOENNE E C, et al. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner[J]. Cancer Res, 2007, 67(4): 1555-1562.
[32]SIMBERG D, DUZA T, PARK J H, et al. Biomimetic amplification of nanoparticle homing to tumors[J]. Proc Natl Acad Sci USA, 2007, 104(3): 932-936.
[33]KELLY K A, ALLPOTR J R, TSOURKAS A, et al. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle[J]. Circ Res, 2005, 96(3): 327-336.
[34]MONTET X, WEISSLEDER R, JOSEPHSON L. Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas[J]. Bioconjugate Chem, 2006, 17(4): 905-911.
[35]MOORE A, MEDAROVA Z, POTTHAST A, et al. In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe[J]. Cancer Res, 2004, 64(5): 1821-1827.
[36]LEUSCHNER C, KUMAR C S, HANSEL W, et al. LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases[J]. Breast Cancer Res Treat, 2006, 99(2): 163-176.
[37]IQBAL M Z, MA X, CHEN T, et al. Silica-coated super-paramagnetic iron oxide nanoparticles(SPIONPs): A new type contrast agent of T 1 magnetic resonance imaging(MRI)[J]. J Mater Chem B, 2015, 3(26): 5172-5181.
[38]THU H P, NAM N H, QUANG B T, et al. In vitro, and in vivo, targeting effect of folate decorated paclitaxel loaded PLA-TPGS nanoparticles[J]. Saudi Pharm J, 2015, 23(6): 683-688.